Skip to content
MedsAcross

Brand family

Skytrofa

Lonapegsomatropin · Ascendis Pharma Endocrinology
United States
Presentations
14
Markets
1

Skytrofa is a brand of Lonapegsomatropin marketed by Ascendis Pharma Endocrinology, with 14 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Lonapegsomatropin
Brand owner
Ascendis Pharma Endocrinology
Registered in
United States
Strengths and forms
0.7 mg powder for injection, 1.4 mg powder for injection, 1.8 mg powder for injection, 11 mg powder for injection, 13.3 mg powder for injection, 2.1 mg powder for injection, 2.5 mg powder for injection, 3 mg powder for injection, 3.6 mg powder for injection, 4.3 mg powder for injection, 5.2 mg powder for injection, 6.3 mg powder for injection, 7.6 mg powder for injection, 9.1 mg powder for injection

All presentations

MedicineManufacturerRegisterAvailability
Skytrofa 0.7 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 1.4 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 1.8 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 11 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 13.3 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 2.1 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 2.5 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 3 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 3.6 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 4.3 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 5.2 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 6.3 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 7.6 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request
Skytrofa 9.1 mg powder for injectionSubcutaneous Cold chainAscendis Pharma EndocrinologyUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Skytrofa

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.